A Trial to Compare Treatment With Surlorian (ARM210, S48168) to Placebo in Effects on Muscle Strength and Safety in Adults With Autosomal Dominant RYR1-related Myopathy

NCT07560020 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Autosomal Dominant RYR1-Related Myopathy

Interventions

DRUG: Surlorian
OTHER: Placebo

Sponsor

RyCarma Therapeutics, Inc.